Literature DB >> 17174095

CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.

Daniel A Ritt1, Ming Zhou, Thomas P Conrads, Timothy D Veenstra, Terry D Copeland, Deborah K Morrison.   

Abstract

Kinase Suppressor of Ras (KSR) is a molecular scaffold that interacts with the core kinase components of the ERK cascade, Raf, MEK, and ERK and provides spatial and temporal regulation of Ras-dependent ERK cascade signaling. In this report, we identify the heterotetrameric protein kinase, casein kinase 2 (CK2), as a new KSR1-binding partner. Moreover, we find that the KSR1/CK2 interaction is required for KSR1 to maximally facilitate ERK cascade signaling and contributes to the regulation of Raf kinase activity. Binding of the CK2 holoenzyme is constitutive and requires the basic surface region of the KSR1 atypical C1 domain. Loss of CK2 binding does not alter the membrane translocation of KSR1 or its interaction with ERK cascade components; however, disruption of the KSR1/CK2 interaction or inhibition of CK2 activity significantly reduces the growth-factor-induced phosphorylation of C-Raf and B-Raf on the activating serine site in the negative-charge regulatory region (N-region). This decrease in Raf N-region phosphorylation further correlates with impaired Raf, MEK, and ERK activation. These findings identify CK2 as a novel component of the KSR1 scaffolding complex that facilitates ERK cascade signaling by functioning as a Raf family N-Region kinase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17174095     DOI: 10.1016/j.cub.2006.11.061

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  54 in total

Review 1.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

2.  The Caenorhabditis elegans ekl (enhancer of ksr-1 lethality) genes include putative components of a germline small RNA pathway.

Authors:  Christian E Rocheleau; Kevin Cullison; Kai Huang; Yelena Bernstein; Annina C Spilker; Meera V Sundaram
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

3.  Cancer: Melanoma troops massed.

Authors:  Paul H Huang; Richard Marais
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

4.  KSR1 modulates the sensitivity of mitogen-activated protein kinase pathway activation in T cells without altering fundamental system outputs.

Authors:  Joseph Lin; Angus Harding; Emanuele Giurisato; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

5.  The protein kinase 2 inhibitor CX-4945 regulates osteoclast and osteoblast differentiation in vitro.

Authors:  You Hwa Son; Seong Hee Moon; Jiyeon Kim
Journal:  Mol Cells       Date:  2013-10-22       Impact factor: 5.034

6.  Activation of the MAPK module from different spatial locations generates distinct system outputs.

Authors:  Kerry Inder; Angus Harding; Sarah J Plowman; Mark R Philips; Robert G Parton; John F Hancock
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

7.  Differential regulation of mitogen- and stress-activated protein kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV radiation.

Authors:  Kellie A Jacks; C Anne Koch
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

8.  KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals.

Authors:  Michele K Dougherty; Daniel A Ritt; Ming Zhou; Suzanne I Specht; Daniel M Monson; Timothy D Veenstra; Deborah K Morrison
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

9.  IQGAP1 integrates Ca2+/calmodulin and B-Raf signaling.

Authors:  Jian-Guo Ren; Zhigang Li; David B Sacks
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

10.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.